GlassScriptPhysician profile
Mark B Kabins
NPI 1194714030
$118,412.06
in general payments reported to CMS, 2019-2025
15 companies · $17K in 2025
The $17K reported for 2025 was more than what 77% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $18K · 2021: $23K · 2022: $16K · 2023: $15K · 2024: $8,018 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $40K · Food and Beverage: $959.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $39,894.90 |
| Food and Beverage | $959.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Precision Spine, INC. | $71,677.19 | 2019-2025 | |
| Orthofix Medical, INC. | $41,976.49 | 2019-2025 | Unity, Physio-Stim, Spinal-Stim |
| Nuvasive, INC. | $2,302.77 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $1,177.69 | 2019-2020 | |
| Zimvie INC. | $281.17 | 2022-2023 | |
| Providence Medical Technology, INC. | $270.20 | 2023-2025 | |
| Amplify Surgical, INC. | $167.57 | 2022 | |
| Medtronic, INC. | $152.61 | 2022-2025 | Mazor X System, Inceptiv |
| Si-Bone, INC. | $124.02 | 2022-2025 | |
| Nevro Corp. | $106.21 | 2023 | Senza |
| Smith+Nephew, INC. | $57.99 | 2019 | |
| Medtronic USA, INC. | $56.50 | 2019 | |
| Bioventus LLC | $33.52 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Life Spine, INC. | $17.11 | 2020 | |
| Spineology INC. | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Kabins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.